Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huashifengdu granules is a Traditional Chinese Medicine (TCM) hospital preparation developed by Shenzhen Children's Hospital for the treatment of pediatric influenza and other viral respiratory infections. The formula is designed based on TCM principles to clear heat, resolve dampness, and detoxify, specifically targeting the damp-toxin and wind-heat patterns often observed in children with respiratory illnesses. It is registered as a hospital-made preparation (院内制剂) in China, allowing it to be prescribed and dispensed within the clinical network of the developing institution. The medication aims to alleviate symptoms such as fever, cough, and malaise by modulating the body's immune response and exerting broad-spectrum antiviral and anti-inflammatory activities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on huashifengdu granules.